SQI Diagnostics (TSXV:SQD) Can Multiplex a Blood Test: CEO

SQI Diagnostics Inc. (TSXV:SQD) CEO Andrew Morris said SQI has added three Big Pharma companies and expects to generate recurring revenue

In this interview with SmallCapPower from the Cantech Investment Conference 2018, SQI Diagnostics Inc. (TSXV:SQD) CEO Andrew Morris explains how SQI’s microarray diagnostics plate can do multiple blood tests from just one sample, resulting in substantial savings for diagnostic laboratories. Watch our short video interview to discover some of the catalysts that could potentially move SQI’s stock price, including the addition of “three Big Pharma companies,” as well as the generation of recurring revenue.

See more exclusive Cantech Investment Conference 2018 interviews here >>

To read our full disclosure, please click on the button below: